Netherlands: ECAF invests in DORC to help with China market entry

Marc Frappier, managing partner, Eurazeo Capital

The Eurazeo China Acceleration Fund (ECAF) has invested €80m (US$94.8m) in DORC (Dutch Ophthalmic Research Centre) to help it invest in China. Paris-based Eurazeo Capital is already an investor in DORC and the private equity group said that this syndication has no impact on the other funds managed by Eurazeo. DORC designs, manufactures and distributes…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »